Purple Biotech (PPBT) Net Income (2014 - 2026)

Purple Biotech (PPBT) has reported Net Income for 10 consecutive years, with -$89000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Income rose 80.48% year-over-year to -$89000.0 in Q1 2026; TTM through Mar 2026 was -$2.9 million, a 59.85% increase from a year earlier, with the FY2023 full-year figure at -$25.5 million, down 7.96% from the prior year.
• Net Income was -$89000.0 for Q1 2026 at Purple Biotech, up from -$1.3 million in the prior quarter.
• Over five years, Net Income peaked at -$89000.0 in Q1 2026 and troughed at -$7.3 million in Q1 2022.
• A 5-year average of -$3.1 million and a median of -$3.6 million in 2022 frame the typical range for Net Income.
• Across the five-year window, Net Income plunged 177500.0% in 2022 and surged 87.94% in 2025, its largest moves.
• Over 5 years, Net Income stood at -$4.8 million in 2022, then decreased by 4.25% to -$5.1 million in 2023, then soared by 86.79% to -$668000.0 in 2024, then sank by 95.36% to -$1.3 million in 2025, then surged by 93.18% to -$89000.0 in 2026.
• The last three Net Income figures came in at -$89000.0 (Q1 2026), -$1.3 million (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.